MV Mateos
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 42
- Multiple Myeloma Research and Treatments 37
- Hematopoietic Stem Cell Transplantation 5
- Oncology 26
- Cancer Treatment and Pharmacology 10
- Peptidase Inhibition and Analysis 6
- CAR-T cell therapy research 3
- Co-authors
- Jesús F. San Miguel (18 shared papers)Marcos González (4 shared papers)Dolores Caballero (3 shared papers)María‐Belén Vídriales (2 shared papers)José Antonio Pérez‐Simón (3 shared papers)Lourdes Vázquez (2 shared papers)Saad Z. Usmani (5 shared papers)Manisha Bhutani (1 shared paper)
- Journals
- Leukemia (14 papers)Bone Marrow Transplantation (4 papers)Annals of Oncology (4 papers)Haematologica (4 papers)HemaSphere (4 papers)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
MV Mateos
44 papers receiving 2.0k citations
MV Mateos's Hit Papers
Peers
Comparison fields: 5 of 74
- Hematology 1.7k
- Oncology 718
- Genetics 267
- Transplantation 33
- Molecular Biology 890
Countries citing papers authored by MV Mateos
This map shows the geographic impact of MV Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MV Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MV Mateos more than expected).
Fields of papers citing papers by MV Mateos
This network shows the impact of papers produced by MV Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MV Mateos. The network helps show where MV Mateos may publish in the future.
Co-authors
The 25 scholars most cited alongside MV Mateos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma Hit paper breakdown → | 2017 | 527 |
| 2 | 2011 | 222 | |
| 3 | 2012 | 151 | |
| 4 | 1998 | 142 | |
| 5 | 2014 | 99 | |
| 6 | 2002 | 92 | |
| 7 | 2013 | 78 | |
| 8 | 2011 | 74 | |
| 9 | 2008 | 72 | |
| 10 | 2003 | 70 | |
| 11 | 2012 | 65 | |
| 12 | 1999 | 65 | |
| 13 | 2015 | 58 | |
| 14 | 2017 | 44 | |
| 15 | 2007 | 44 | |
| 16 | 2017 | 39 | |
| 17 | 2004 | 33 | |
| 18 | 2017 | 23 | |
| 19 | 2003 | 20 | |
| 20 | 2015 | 20 |
About MV Mateos
MV Mateos is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Transplantation, having authored 44 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (13 papers), Cancer Treatment and Pharmacology (10 papers), Peptidase Inhibition and Analysis (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (1.7k citations), Oncology (718 citations), Genetics (267 citations), Transplantation (33 citations) and Molecular Biology (890 citations). MV Mateos has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Jesús F. San Miguel, Marcos González, Dolores Caballero, María‐Belén Vídriales, José Antonio Pérez‐Simón, Lourdes Vázquez, Saad Z. Usmani, Manisha Bhutani, Paula Rodríguez‐Otero and Marı́a Dolores Caballero. Their work appears in journals such as Leukemia, Bone Marrow Transplantation, Annals of Oncology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.